2013
Socioeconomic Disparities in the Use of Cardioprotective Medications Among Patients With Peripheral Artery Disease An Analysis of the American College of Cardiology's NCDR PINNACLE Registry
Subherwal S, Patel MR, Tang F, Smolderen KG, Jones WS, Tsai TT, Ting HH, Bhatt DL, Spertus JA, Chan PS. Socioeconomic Disparities in the Use of Cardioprotective Medications Among Patients With Peripheral Artery Disease An Analysis of the American College of Cardiology's NCDR PINNACLE Registry. Journal Of The American College Of Cardiology 2013, 62: 51-57. PMID: 23643497, PMCID: PMC3912073, DOI: 10.1016/j.jacc.2013.04.018.Peer-Reviewed Original ResearchConceptsPeripheral artery diseaseAntiplatelet therapyLow socioeconomic statusSocioeconomic statusCardioprotective medicationsPINNACLE RegistryPAD patientsPractice sitesClinical characteristicsArtery diseaseTreatment disparitiesTreatment of PADQuintile of SESPotential treatment disparitiesSecondary preventive medicationsSecondary preventive treatmentPatients' clinical characteristicsSecondary preventive measuresPatient's zip codeZip codesLowest SES quintileHighest SES quintileStatin medicationCardiovascular riskPreventive medicationsTreatment Differences by Health Insurance Among Outpatients With Coronary Artery Disease Insights From the National Cardiovascular Data Registry
Smolderen KG, Spertus JA, Tang F, Oetgen W, Borden WB, Ting HH, Chan PS. Treatment Differences by Health Insurance Among Outpatients With Coronary Artery Disease Insights From the National Cardiovascular Data Registry. Journal Of The American College Of Cardiology 2013, 61: 1069-1075. PMID: 23375933, PMCID: PMC3641586, DOI: 10.1016/j.jacc.2012.11.058.Peer-Reviewed Original ResearchMeSH KeywordsAdrenergic beta-AntagonistsAmbulatory CareAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsCoronary Artery DiseaseDrug UtilizationFemaleHumansHypolipidemic AgentsInsurance, HealthMaleMedicaidMedically UninsuredMedicareMiddle AgedPlatelet Aggregation InhibitorsRegistriesUnited StatesUnited States Department of Veterans AffairsUnited States Indian Health ServiceConceptsCoronary artery diseaseUninsured patientsEvidence-based treatmentsInsurance statusARB therapyAngiotensin-converting enzyme inhibitors/angiotensin II receptor blockersEnzyme inhibitors/angiotensin II receptor blockersAngiotensin II receptor blockersNational Cardiovascular Data RegistryPublic insuranceEvidence-based medicationsLipid-lowering therapyII receptor blockersLeft ventricular dysfunctionHealth insuranceTreatment differencesPoisson regression modelsPINNACLE RegistryPhysician adherenceVentricular dysfunctionReceptor blockersArtery diseaseCardiac RegistryCardiac outpatientsData registry
2012
SOCIOECONOMIC DISPARITIES IN USE OF CARDIOPROTECTIVE MEDICATIONS AMONG PATIENTS WITH PERIPHERAL ARTERIAL DISEASE_AN ANALYSIS OF THE AMERICAN COLLEGE OF CARDIOLOGY'S NCDR PINNACLE REGISTRY
Subherwal S, Patel M, Tang F, Smolderen K, Jones W, Ting H, Tsai T, Spertus J, Chan P. SOCIOECONOMIC DISPARITIES IN USE OF CARDIOPROTECTIVE MEDICATIONS AMONG PATIENTS WITH PERIPHERAL ARTERIAL DISEASE_AN ANALYSIS OF THE AMERICAN COLLEGE OF CARDIOLOGY'S NCDR PINNACLE REGISTRY. Journal Of The American College Of Cardiology 2012, 59: e1838. DOI: 10.1016/s0735-1097(12)61839-7.Peer-Reviewed Original Research